1. Fastag E, Varon J, Sternbach G. Richard Lower: the origins of blood transfusion. J Emerg Med. 2013; 44(6):1146–1150. PMID:
23499352.
3. Klein HG. Should blood be an essential medicine? N Engl J Med. 2013; 368(3):199–201. PMID:
23323895.
4. Dzik WH. Innocent lives lost and saved: the importance of blood transfusion for children in sub-Saharan Africa. BMC Med. 2015; 13(1):22. PMID:
25640864.
5. Roberts N, James S, Delaney M, Fitzmaurice C. The global need and availability of blood products: a modelling study. Lancet Haematol. 2019; 6(12):e606–e615. PMID:
31631023.
6. Roh J, Choi SJ, Kim S, Min H, Kim HO. Blood supply and demand in Korea: what is in store for the future? Yonsei Med J. 2020; 61(5):400–405. PMID:
32390363.
7. Greinacher A, Fendrich K, Brzenska R, Kiefel V, Hoffmann W. Implications of demographics on future blood supply: a population-based cross-sectional study. Transfusion. 2011; 51(4):702–709. PMID:
20849411.
8. Greinacher A, Weitmann K, Schönborn L, Alpen U, Gloger D, Stangenberg W, et al. A population-based longitudinal study on the implication of demographic changes on blood donation and transfusion demand. Blood Adv. 2017; 1(14):867–874. PMID:
29296730.
9. Goldman M, O’Brien SF. Our older population: donors as well as recipients? ISBT Sci Ser. 2017; 12(4):401–404.
10. Drackley A, Newbold KB, Paez A, Heddle N. Forecasting Ontario’s blood supply and demand. Transfusion. 2012; 52(2):366–374. PMID:
21810099.
11. Akita T, Tanaka J, Ohisa M, Sugiyama A, Nishida K, Inoue S, et al. Predicting future blood supply and demand in Japan with a Markov model: application to the sex- and age-specific probability of blood donation. Transfusion. 2016; 56(11):2750–2759. PMID:
27595917.
12. Jökulsdóttir G. The Impact of Demographics on Future Blood Supply and Demand in Iceland. Reykjavik, Iceland: Reykjavík University;2013. p. 1–83.
13. Kasai DT. Preparing for population ageing in the Western Pacific Region. Lancet Reg Health West Pac. 2020; 6:100069. PMID:
34327404.
14. Liu WJ, Chen YY, Hsu LI, Chen JW, Wei ST, Hou SM. An imbalance in blood collection and demand is anticipated to occur in the near future in Taiwan. J Formos Med Assoc. 2022; 121(8):1610–1614. PMID:
34407921.
15. Volken T, Buser A, Castelli D, Fontana S, Frey BM, Rüsges-Wolter I, et al. Red blood cell use in Switzerland: trends and demographic challenges. Blood Transfus. 2018; 16(1):73–82. PMID:
27723455.
16. Ali A, Auvinen MK, Rautonen J. The aging population poses a global challenge for blood services. Transfusion. 2010; 50(3):584–588. PMID:
19912582.
17. Yu X, Wang Z, Shen Y, Liu Z, Wang H, Zhang S, et al. Population-based projections of blood supply and demand, China, 2017-2036. Bull World Health Organ. 2020; 98(1):10–18. PMID:
31902958.
18. Kim KW, Kim OS. Super aging in South Korea unstoppable but mitigatable: a sub-national scale population projection for best policy planning. Spat Demogr. 2020; 8(2):155–173. PMID:
34222615.
19. Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet. 2017; 389(10076):1323–1335. PMID:
28236464.
21. Health Insurance Review & Assessment Service. Transfusion Demand Data by Year and Age, 2010-2017. Wonju, Korea: Health Insurance Review & Assessment Service;2018.
22. Kim OS, Han J, Kim KW, Matthews SA, Shim C. Depopulation, super aging, and extreme heat events in South Korea. Clim Risk Manage. 2022; 38:100456.
23. Zeiler T, Lander-Kox J, Eichler H, Alt T, Bux J. The safety of blood donation by elderly blood donors. Vox Sang. 2011; 101(4):313–319. PMID:
21535439.
24. Weidmann C, Schneider S, Litaker D, Weck E, Klüter H. A spatial regression analysis of German community characteristics associated with voluntary non-remunerated blood donor rates. Vox Sang. 2012; 102(1):47–54. PMID:
21534984.
27. Makizako H, Nishita Y, Jeong S, Otsuka R, Shimada H, Iijima K, et al. Trends in the prevalence of frailty in Japan: a meta-analysis from the Ilsa-J. J Frailty Aging. 2021; 10(3):211–218. PMID:
34105703.
28. Wiltbank TB, Giordano GF, Kamel H, Tomasulo P, Custer B. Faint and prefaint reactions in whole-blood donors: an analysis of predonation measurements and their predictive value. Transfusion. 2008; 48(9):1799–1808. PMID:
18482188.
29. Eder AF, Dy BA, Kennedy JM, Notari Iv EP, Strupp A, Wissel ME, et al. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006. Transfusion. 2008; 48(9):1809–1819. PMID:
18631167.
30. Callum JL, Waters JH, Shaz BH, Sloan SR, Murphy MF. The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine. Transfusion. 2014; 54(9):2344–2352. PMID:
25100209.
31. Hicks CW, Liu J, Yang WW, DiBrito SR, Johnson DJ, Brito A, et al. A comprehensive Choosing Wisely quality improvement initiative reduces unnecessary transfusions in an Academic Department of Surgery. Am J Surg. 2017; 214(4):571–576. PMID:
28683893.
32. Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017; 57(6):1347–1358. PMID:
28150313.
33. Sadana D, Pratzer A, Scher LJ, Saag HS, Adler N, Volpicelli FM, et al. Promoting high-value practice by reducing unnecessary transfusions with a patient blood management program. JAMA Intern Med. 2018; 178(1):116–122. PMID:
29159367.
34. Bialas C, Moser C, Sims CA. Artificial oxygen carriers and red blood cell substitutes: A historic overview and recent developments toward military and clinical relevance. J Trauma Acute Care Surg. 2019; 87(1S):Suppl 1. S48–S58. PMID:
31246907.
35. Wang Y, Han W, Pan L, Wang C, Liu Y, Hu W, et al. Impact of COVID-19 on blood centres in Zhejiang province China. Vox Sang. 2020; 115(6):502–506. PMID:
32347566.